• OPEN AN ACCOUNT
Indian Indices
Nifty
25,244.75 200.40
(0.80%)
Sensex
82,755.51 700.40
( 0.85%)
Bank Nifty
56,621.15 159.25
( 0.28%)
Nifty IT
39,046.30 628.35
( 1.64%)
Global Indices
Nasdaq
43,117.37 514.58
(1.21%)
Dow Jones
6,114.62 68.45
(1.13%)
Hang Seng
38,915.23 124.67
(0.32%)
Nikkei 225
8,758.99 0.95
(0.01%)
Forex
USD-INR
86.62 0.13
(0.15%)
EUR-INR
99.78 0.17
(0.17%)
GBP-INR
116.55 0.28
(0.24%)
JPY-INR
0.59 0.00
(-0.28%)

EQUITY - MARKET SCREENER

Parnax Lab Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
506128
INE383L01019
19.6294356
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
81.86
113.77
EPS(TTM)
Face Value()
Div & Yield %
1.21
10
0
 

Birlasoft consolidated net profit declines 32.19% in the March 2025 quarter
May 29,2025
Net profit of Birlasoft declined 32.19% to Rs 122.11 crore in the quarter ended March 2025 as against Rs 180.08 crore during the previous quarter ended March 2024. Sales declined 3.35% to Rs 1316.89 crore in the quarter ended March 2025 as against Rs 1362.55 crore during the previous quarter ended March 2024.

For the full year,net profit declined 17.15% to Rs 516.76 crore in the year ended March 2025 as against Rs 623.76 crore during the previous year ended March 2024. Sales rose 1.84% to Rs 5375.24 crore in the year ended March 2025 as against Rs 5278.15 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales1316.891362.55 -3 5375.245278.15 2
OPM %13.1816.27 -12.9815.84 -
PBDT187.94263.31 -29 782.54919.79 -15
PBT166.30242.22 -31 696.83834.76 -17
NP122.11180.08 -32 516.76623.76 -17